Functional IOL Implantation in Patients With Epiretinal Membrane
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-90
SponsorEye & ENT Hospital of Fudan University
About this trial
We have designed this prospective study to evaluate macular involvement and epiretinal membrane (ERM) grading by OCT in eyes with ERM and to compare clinical outcomes after implantation of Enhance IOL with standard monofocal IOL in eyes with ERM grading preoperatively, aiming to find out whether functional IOL is benefit for patients with ERM.
Eligibility criteria
Qualifiers
Requirement for cataract extraction
Age > 40 years
Axial length in 21mm to 25mm
ERM
Disqualifiers
Residual corneal astigmatism > 1.0 D
Amblyopia
Previous ocular surgery
Other ocular pathologies apart from mERM, such as diabetic retinopathy, macular degeneration, glaucoma with field defects
Trial design
Treatments tested in this trial
- Intraocular lens implantation
Treatment groups
90 Participants
are divided into 2 treatment groupsLocations
2Eye and Ear, Nose, and Throat Hospital of Fudan University200031, ShanghaiShanghai Municipality, China
Shanghai Heping Eye Hospital200081, ShanghaiShanghai Municipality, China
Sponsors and collaborators
Eye & ENT Hospital of Fudan University
Lead sponsor
Source ClinicalTrials.gov